Language isolate

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List

Retrieved on: 
星期三, 一月 18, 2023
Software, Pharmaceutical, Managed Care, General Health, Health, Health Technology, Technology, Clinical Trials, Reading, Policy by press release, Publication, PDT, Therapy, Medicaid, Pear, Buprenorphine, Language isolate, United States drug overdose death rates and totals over time, Florida Medicaid waiver, OUD, Methamphetamine, SUD, FDA, Risk, Smartphone, Substance use disorder, Patient, Cannabis, PDL, Cocaine, Suicidal ideation, Reset, CDC, Cognitive behavioral therapy, Opioid use disorder, Pharmaceutical industry, Medical device, Birth control, Hospital, Mobile phone

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the inclusion of its PDTs reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List (PDL).

Key Points: 
  • Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the inclusion of its PDTs reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List (PDL).
  • reSET and reSET-O, the only FDA-authorized PDTs for the treatment of substance use disorder and opioid use disorder, respectively, have been added to the Florida Medicaid PDL, effective January 1, 2023.
  • Increase abstinence from a patient’s substances of abuse during treatment, and
    Increase retention in the outpatient treatment program.
  • The long-term benefit of reSET-O has not been evaluated in studies lasting beyond 12 weeks (84 days) in the OUD population.

Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics

Retrieved on: 
星期二, 一月 10, 2023
Health, Technology, Health Technology, Managed Care, Software, General Health, Pharmaceutical, PDT, Reading, Press release, Therapy, Medicaid, Pear, Buprenorphine, Language isolate, OUD, CMS, Government, Centers for Medicare & Medicaid Services, SUD, Risk, Smartphone, Substance use disorder, Medicare, Patient, Suicidal ideation, Reset, Multimedia, Commercial, Cognitive behavioral therapy, Opioid use disorder, Pharmaceutical industry, Health insurance, Birth control, Hospital, Mobile phone, Medical device

Pear Therapeutics, Inc. (Nasdaq: PEAR) (“Pear”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced an agreement with COEUS HealthCare, LLC (“COEUS”), a leading life sciences technology and consulting firm, to utilize its outcomes and evidence-based reimbursement adjudication platform, COEBRA™ to help enable value-based contracting.

Key Points: 
  • Pear Therapeutics, Inc. (Nasdaq: PEAR) (“Pear”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced an agreement with COEUS HealthCare, LLC (“COEUS”), a leading life sciences technology and consulting firm, to utilize its outcomes and evidence-based reimbursement adjudication platform, COEBRA™ to help enable value-based contracting.
  • The agreement between COEUS and Pear could help unlock the potential value that Pear’s PDTs can deliver.
  • Hosting PDTs on the COEUS COEBRATM Platform is intended to provide scalability for Pear across multiple channels including Medicaid, Commercial and other government payers.
  • As part of the agreement, COEUS will provide Pear a turnkey value-based solution that will be made available to most state Medicaid programs.

BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

Retrieved on: 
星期五, 一月 13, 2023
Trust, Language isolate, International, Motherboard, Marketing, History, Growth, Danna International (Offer Nissim Presents), Teleport Communications Group, Neology, Hong Kong Stock Exchange, Stock exchange, CCASS, Property management

The Offer Price is HK$19.32 per share.

Key Points: 
  • The Offer Price is HK$19.32 per share.
  • The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been very significantly oversubscribed.
  • The Offer Shares initially offered under the International Offering have been moderately oversubscribed, representing approximately 4.7 times of the total number of 36,482,500 International Offer Shares initially available for subscription under the International Offering.
  • The outstanding share oversubscription shows the trust and support of global investors for the Company's business development and lays a firm ground for the Company's long-term growth.

Niu Technologies Provides Fourth Quarter 2022 Sales Volume Update

Retrieved on: 
星期五, 一月 6, 2023
NIU, City, Policy, Omicron, Sale, Language isolate, Video game

In the fourth quarter of 2022, NIU sold 138,279 units, including e-motorcycles, e-mopeds, e-bicycles and kick-scooters, representing a 41.9% year-over-year decline.

Key Points: 
  • In the fourth quarter of 2022, NIU sold 138,279 units, including e-motorcycles, e-mopeds, e-bicycles and kick-scooters, representing a 41.9% year-over-year decline.
  • As a result, Niu and Gova premium series contributed 95% of the total domestic sales volume in the fourth quarter.
  • Kick-scooters' sales volume was less than expected because our major strategic partner in Europe underwent business restructuring, causing temporary delay in our sales and channel expansions.
  • Our sales volume count disclosed above is based on the delivery from our manufacturing facility, which may vary slightly from the sales volume measured from a financial accounting and reporting point of view.

Voltron Data Named One of the Hottest Big Data Startups of the Year

Retrieved on: 
星期四, 一月 5, 2023
CRN, Ibis, Partnership, DataStax, Apache, Microsoft, Organization, Meta, Language isolate, API, Apache Arrow, Netflix, Astra, Snowflake, AWS, Data, Modularity, Love, Video game, Computer data storage, Arrow

SAN FRANCISCO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Voltron Data, the company accelerating standards in data analytics and the largest corporate contributor to Apache Arrow, today announced that it has been named one of the 10 hottest big data startups of 2022 by CRN: https://www.crn.com/news/applications-os/the-10-hottest-big-data-startup...

Key Points: 
  • “This year businesses and organizations have sought to leverage data and data analytics to obtain the visibility that will help them navigate rapidly changing business conditions.”
    Voltron Data is committed to developing open source standards for data, unlocking the untapped potential in the data analytics industry.
  • Through these standards, customers can interchange and process massive datasets between the applications and tools they already use and love.
  • June: Voltron Data hosted The Data Thread conference to showcase the latest innovations around Apache Arrow and the Arrow ecosystem with speakers from more than 40 organizations.
  • "Voltron Data is uniquely positioned to support large-scale enterprise and industry adoption of these open standards.”

Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States

Retrieved on: 
星期三, 一月 4, 2023
Technology, Mobile, Wireless, FDA, Health Technology, Software, Managed Care, Health, Pharmaceutical, General Health, Language isolate, Cognitive behavioral therapy, Food, Therapy, Suicidal ideation, Policy by press release, Substance use disorder, Smartphone, Buprenorphine, Multimedia, Risk, Opioid use disorder, Reset, Reading, Patient, Drug overdose, Population Health Management, OUD, PDT, FDA, Pear, Food and Drug Administration Modernization Act of 1997, SUD, Pharmaceutical industry, Hospital, Birth control, Mobile phone, Medical device

Spero Health, which has implemented reSET and reSET-O at 14 locations in Kentucky, intends to expand access to eligible patients at its 99 locations throughout Indiana, Kentucky, Ohio, Tennessee, West Virginia, and Virginia.

Key Points: 
  • Spero Health, which has implemented reSET and reSET-O at 14 locations in Kentucky, intends to expand access to eligible patients at its 99 locations throughout Indiana, Kentucky, Ohio, Tennessee, West Virginia, and Virginia.
  • The expansion is part of Spero Health’s commitment to increase patient engagement and retention in recovery by offering FDA-authorized innovative treatment options.
  • We believe having access to patient reported data via Pear’s clinician dashboard gives us better insight into patient behaviors.
  • “With more than 40 million Americans living with addiction, we are proud to expand our work with Spero Health to help more patients who are seeking recovery solutions,” said Julia Strandberg, Chief Commercial Officer at Pear Therapeutics.

Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP

Retrieved on: 
星期四, 十二月 15, 2022
Technology, Research, FDA, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, Cognitive behavioral therapy, Substance use disorder, Patient, United, Insomnia, United States $1 Coin Act of 1997, Opioid use disorder, FDA, Suicidal ideation, AUD, Reading, Addiction psychiatry, Reset, Policy by press release, Public, PDT, SAMHSA, PEAR, Cannabis, SUD, MD, Pear, Language isolate, MBA, Smartphone, Centers for Disease Control and Prevention, Cocaine, Therapy, Risk, Public health, Pharmaceutical industry, Birth control, Hospital, Health

The real-world observational study evaluated 548 patients with alcohol-related disorders from 28 states who were treated with reSET over 12 weeks.

Key Points: 
  • The real-world observational study evaluated 548 patients with alcohol-related disorders from 28 states who were treated with reSET over 12 weeks.
  • The primary endpoint was engagement with reSET (lessons completed) throughout the prescription, and activity was also assessed as any use of reSET during a given week.
  • These data highlight benefits from reSET, which is indicated to treat addiction to cannabis, cocaine, and stimulants and alcohol when used with another substance.
  • A prescription digital therapeutic for substance use disorder: real-world engagement and abstinence patterns in patients diagnosed with alcohol-related disorders.

Celebrating one-year anniversary of signing of Canada-wide Early Learning and Child Care Agreement with New Brunswick

Retrieved on: 
星期二, 十二月 13, 2022
Innovation, Science and Economic Development Canada, Government of New Brunswick, Heart, Child care, Municipal government in Canada, Atlantic Canada, Life, Partnership, Child, Education, Parent, Woman, Investment, Policy, Social change, Government, Workforce, Language isolate, Healthcare, Toy, Medicine, Tutoring, QC

That's why the Government of Canada signed agreements with every province and territory to implement a Canada-wide early learning and child care system.

Key Points: 
  • That's why the Government of Canada signed agreements with every province and territory to implement a Canada-wide early learning and child care system.
  • Today, the Minister of Families, Children and Social Development, Karina Gould, and New Brunswick's Minister of Education and Early Childhood Development, Bill Hogan, marked the one-year anniversary of the signing of the CanadaNew Brunswick Canada-wide Early Learning and Child Care Agreement.
  • New Brunswick has reduced child care fees for licensed early learning and child care spaces for children under 6 by 50% on average as of June 1, 2022, introduced a new child care space creation policy, and is working toward creating 3,400 new licensed child care spaces by the end of March 2026.
  • Combined with other investments, including investments in Indigenous early learning and child care, up to $30 billion over five years will be provided in support of early learning and child care.

Statement from the Commissioner of Official Languages of Canada on the release of Census data on language of instruction and language of work

Retrieved on: 
星期三, 十一月 30, 2022
Commissioner, Communication, Workplace, Statistics, Rights, Education, Government, Language, Language isolate, Statistics Canada, Immersion, Section 23 of the Canadian Charter of Rights and Freedoms, Federation, Film, Census, QC

The ways we use English and French in educational and work settings have a direct impact on official language communities in every province and territory.

Key Points: 
  • The ways we use English and French in educational and work settings have a direct impact on official language communities in every province and territory.
  • "For the first time, Census data can be used to estimate the numbers of children eligible for instruction in the minority official language and can also provide information on immersion education.
  • According to the data, one third of eligible children across the country have never attended school in the official language of the linguistic minority.
  • That said, I'm very pleased that we now have this important Census data, given how it could influence generations to come.

FAIR Health Initiative Demonstrates Appetite for Shared Decision-Making Tools among Patients of Color

Retrieved on: 
星期二, 十一月 29, 2022
Personal finance, Doctor of Philosophy, Patient, AICPA, CMS, Government, Language isolate, AHRQ, Health, Type 2 diabetes, Organization, HITRUST, PIP, Hospital, Certification, ITI, Caregiver, Kiplinger, Agency, Friends, Database, Centers for Medicare & Medicaid Services, Diabetes, Medicare, FAIR, Agency for Healthcare Research and Quality, Focus, Collection, Medicare Part D, URAC, News, Health insurance

NEW YORK, Nov. 29, 2022 /PRNewswire/ -- An initiative to advance shared decision making among patients of color in New York State revealed an appetite for this type of discussion among patients and providers and the utility of tools that facilitate such discussions. Shared decision making is the exchange among patients, caregivers and healthcare providers, balancing clinical options and patient preferences to make treatment decisions. The initiative, generously funded by the New York Health Foundation (NYHealth) and undertaken in collaboration with FAIR Health Academic Advisory Board member Chima Ndumele, PhD, offered salient insights as to how patients make decisions and challenges they may face when navigating the healthcare system and managing healthcare costs. These and other insights are included in a brief released today by FAIR Health, Advancing Shared Decision Making among Patients of Color: Lessons Learned from FAIR Health's Grant-Funded Initiative.

Key Points: 
  • These and other insights are included in a brief released today by FAIR Health, Advancing Shared Decision Making among Patients of Color: Lessons Learned from FAIR Health's Grant-Funded Initiative .
  • The tools combine clinical and cost information, and reside in a dedicated shared decision-making section of the FAIR Health Consumer (fairhealthconsumer.org) website.
  • FAIR Health promoted the tools through a robust, culturally sensitive dissemination campaign to a variety of stakeholders: providers, patients, community organizations, state and federal departments of health and organizations that serve and advocate for communities of color, among others.
  • Of the initiative, FAIR Health President Robin Gelburd said, "FAIR Health wishes to thank the New York Health Foundation for supporting this groundbreaking initiative.